Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Heart Disease, Ischemic

erlotinib hydrochloride has been researched along with Heart Disease, Ischemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durand, JB; Kim, P; Yusuf, SW1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Heart Disease, Ischemic

ArticleYear
Erlotinib or gefitinib for non-small-cell lung cancer.
    The New England journal of medicine, 2011, 06-16, Volume: 364, Issue:24

    Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Myocardial Ischemia; Protein Kinase Inhibitors; Quinazolines; Stroke

2011